Assessment of a Test for the Screening and Diagnosis of Celiac Disease

Journal of Clinical Laboratory Analysis

Volumn 30, Issue 1, 2016, Pages 65-70

  Porcelli, Brunetta ^a   Ferretti, Fabio ^a   Vindigni, Carla ^b   Terzuoli, Lucia ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Anti cross linked complex antibodies; Antideamidated gliadin peptides antibodies; Antitissue transglutaminase antibodies; Celiac disease; Neoepitope

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; MASS SCREENING; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84954060623     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21816     Document Type: Article

References (26)

1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 2001;120:636-651.
2. Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275-2279.
3. Fleckenstein B, Molberg O, Qiao SW, et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 2002;277:34109-34116.
4. Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004;279:17607-17616.
5. Skovbjerg H, Koch C, Anthonsen D, Sjostrom H. Deamidation and cross-linking of gliadin peptides by transglutaminase and the relation to celiac disease. Biochim Biophys Acta 2004;1690:220-230.
6. Ciccocioppo R, Di Sabatino A, Ara C, et al. Gliadin and tissue transglutaminase complexes in normal and celiac duodenal mucosa. Clin Exp Immunol 2003;134:516-524.
7. Mowat AM. Coeliac disease-a meeting point for genetics, immunology, and protein chemistry. Lancet 2003;361:1290-1292.
8. Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003;132:98-108.
9. Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int J Biochem Cell Biol 2004;36:17-24.
10. Tonutti E, Visentini D, Bizzaro N, et al. The role of anti-tissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: A French-Italian multicentre study. J Clin Pathol 2003;56:389-393.
11. Korponay-Szabò IR, Dahlbom I, Laurila J, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for celiac disease in selective IgA deficiency. Gut 2003;52:1567-1571.
12. Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vacc Immunol 2006;13:150-151.
13. Sugai E, Vazquez H, Nachman F, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006;4:1112-1117.
14. Volta U, Granito A, Fiorini E, et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow up. Dig Dis Sci 2008;53:1582-1588.
15. Marietta EV, Rashtak S, Murray JA. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA. World J Gastroenterol 2009;15:845-848.
16. Jaskowski TD, Donaldson MR, Hull CM, et al. Novel screening assay performance in pediatric celiac disease and adult dermatitis herpetiformis. J Pediatr Gastroenterol Nutr 2010;51:19-23.
17. Sugai E, Nachman F, Váquez H, et al. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis 2010;42:352-358.
18. Vermeersch P, Geboes K, Mariën GA, Hoffman I, Hiele M, Bossuyt X. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Clin Chim Acta 2010;411:931-935.
19. Villalta D, Tonutti E, Prause C, et al. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem 2010;56:464-468.
20. Matthias T, Pfeiffer S, Selmi C, Eric Gershwin M. Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. Clin Rev Allergy Immunol 2010;38:298-301.
21. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: Time for a standardized report scheme for pathologist. Eur J Gastroenterol Hepatol 1999;11:1185-1194.
22. NIH Consensus Development Conference on Celiac Disease, Bethesda 2004. Available from: http://www.consensusnih.gov/cons/118/118cdc_intro.htm.
23. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
24. Fleiss J, Cohen J, Everett BS. Large sample standard errors of kappa and weighted kappa. Psychol Bull 1969;72:323-327.
25. Green PH, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: Results of a national survey. Am J Gastroenterol 2001;96:126-131.
26. Tonutti E, Visentini D, Fabris M, et al. Antibodies to the transglutaminase-deamidated gliadin peptides complex: A new serological approach to the diagnosis of celiac disease, 7th International Congress on Autoimmunity 2010, Ljubljana, Slovenia.